Research

Life Sciences & Biotechnology

Title :

The drugability of a novel anti-diabetic pancreastatin inhibitor PSTi8: Preclinical pharmacokinetic & drug-drug interaction studies

Area of research :

Life Sciences & Biotechnology

Focus area :

Science & Engineering Research Board - Core Research Grant, SERB-CRG

Principal Investigator :

Dr. J.R. Gayen, Sr. Scientist, CSIR-Central Drug Research Institute, Uttar Pradesh

Timeline Start Year :

2019

Timeline End Year :

2022

Details

Total Budget (INR):

50,43,240

Organizations involved